Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04116385 · ClinicalTrials.gov registry record

Evaluation of the Quantra System in a Surgical Oncological Population

A clinical trial, sponsored by HemoSonics.

Completed
Registry status
75
Enrollment target

NCT04116385 is a clinical trial that has completed, run by HemoSonics. The registered enrollment target is 75 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04116385 has completed, sponsored by HemoSonics.

COMPLETED
Registry status
75 participants
Enrollment target

Study Summary

This study will monitor coagulation parameters during the perioperative course of cancer surgical procedures using the Quantra System with the QPlus Cartridge.

Interventions

  • DIAGNOSTIC_TEST Quantra System

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2019-08-15
Est. Completion 2020-07-30

Sponsor

HemoSonics

24 total trials

What the Registry Record Tells You About NCT04116385

The ClinicalTrials.gov registry entry for NCT04116385 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HemoSonics, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Quantra System is the first listed.

NCT04116385 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04116385 about?

NCT04116385 is a clinical study titled "Evaluation of the Quantra System in a Surgical Oncological Population". This study will monitor coagulation parameters during the perioperative course of cancer surgical procedures using the Quantra System with the QPlus Cartridge.

What is the current status of trial NCT04116385?

This trial is currently completed. The enrollment target is 75 participants. The study started on 2019-08-15. Estimated completion is 2020-07-30.

What interventions are being tested in trial NCT04116385?

The interventions under investigation include: Quantra System (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04116385?

This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.